The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator ... or Asthma Control Test or COPD Assessment Test); Requires ...
Ensifentrine is billed as a first-in-class dual inhibitor of the enzymes phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator and anti-inflammatory properties in one ...
Patients in the studies were also being treated with medium to high-dose inhaled corticosteroids (ICS), plus at least one additional bronchodilator therapy. "As a physician, it is encouraging to ...
TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...
Cholinergic drugs (acetylcholine and methacholine) are usually used for the assessment of nonspecific bronchial hyperresponsiveness, due to the high sensitivity of this test. The cholinergic ...
You can access a range of bibliographical databases with your NHS OpenAthens account. Sign in to see what you can access. You can access bibliographic databases from the providers' websites. For ...
Aug. 8, 2024 — A new study suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck ... New Study Finds 40-Percent ...
June 11, 2024 — Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study has identified two types of these so-called dysbioses in cystic ...
Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...
1 Department of Pulmonary and Intensive Care Medicine, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands 2 Department of Biostatistics, Erasmus Medical Center Rotterdam Correspondence to: ...